February 4, 2021
Shortages of many essential drugs amid the COVID-19 crisis reveal serious vulnerabilities in the systems for supplying and distributing pharmaceuticals in the United States.
January 21, 2021
Survey: Frequent Reports of Missed Medical Care in U.S. Adults During the Early Phase of the COVID-19 Pandemic
Two out of five individuals delayed or missed medical care in the early phase of the pandemic—from March through mid-July 2020.
January 7, 2021
COVID-19 Outcomes for Patients on Immunosuppressive Drugs on Par with Non- Immunosuppressed Patients
People taking immunosuppressive drugs to prevent organ transplant rejection or to treat inflammatory or autoimmune diseases do not fare worse than others on average when they are hospitalized with COVID-19.
December 21, 2020
A new report from researchers at the Johns Hopkins Bloomberg School of Public Health offers recommendations aimed at federal, state, and local policymakers to address the opioid epidemic during the pandemic, which has seen sharp increases in fatal and nonfatal overdoses.
November 13, 2020
A new saliva-based test developed by a team at Johns Hopkins Bloomberg School of Public Health has been found to accurately detect the presence of antibodies to SARS-CoV-2, the virus that causes COVID-19.
October 28, 2020
Researchers at the Bloomberg School and School of Medicine have been jointly awarded a major grant from the National Cancer Institute to set up a center for research on the human serological immune response to COVID-19.
October 21, 2020
Americans strongly reduced their visits to grocery stores, pharmacies, and transit stations following stay-at-home orders from mayors and governors earlier this year, but did not reduce their visits to parks and beaches.
October 19, 2020
Sex, age, and severity of disease may be useful in identifying COVID-19 survivors who are likely to have high levels of antibodies that can protect against the disease.
October 15, 2020
Survey: More U.S. Adults Want the Government to Have a Bigger Role in Improving Peoples' Lives Than Before the Pandemic
The share of U.S. adults who support an active government role in society increased by more than 40 percent during the initial pandemic response.
October 2, 2020
Study Highlights Shortcomings in Telemedicine Despite Large Increases in Remote Consults During COVID-19 Pandemic
Despite increased use of telemedicine during the COVID-19 pandemic, Americans have had significantly fewer consultations with primary care doctors and markedly fewer assessments of common cardiac risk factors.
September 10, 2020
Using public transportation, visiting a place of worship, or otherwise traveling from the home is associated with a significantly higher likelihood of testing positive with the coronavirus SARS-CoV-2.
July 30, 2020
Johns Hopkins Receives $35 Million in Funding from Department of Defense for COVID-19 Blood Plasma Trials
Johns Hopkins researchers have received $35 million in funding from the U.S. Department of Defense (DOD) JPEO-CBRND, on behalf of the Defense Health Agency, for two nationwide clinical trials.
July 8, 2020
A new analysis led by researchers at Johns Hopkins Bloomberg School of Public Health found that the number of U.S. prison residents who tested positive for COVID-19 was 5.5 times higher than the general U.S. population.
June 18, 2020
Study: Urban Density Not Linked to Higher Coronavirus Infection Rates—and Is Linked to Lower COVID-19 Death Rates
A new study suggests that denser places, assumed by many to be more conducive to the spread of the coronavirus that causes COVID-19, are not linked to higher infection rates.
June 15, 2020
Many Americans could face high out-of-pocket medical costs for COVID-19 hospitalizations despite the fact that many insurers have waived their cost-sharing requirements.
June 9, 2020
Most of the registered clinical trials of potential treatments for COVID-19 underway as of late March were designed in ways that will greatly limit their value in understanding potential treatments, according to a study from researchers at JHSPH.
June 3, 2020
Survey Finds Large Increase in Psychological Distress Reported Among U.S. Adults During the COVID-19 Pandemic
A new survey conducted by researchers at JHSPH during the COVID-19 pandemic found a more-than-threefold increase in the percentage of U.S. adults who reported symptoms of psychological distress—from 3.9 percent in 2018 to 13.6 percent in April 2020.
May 11, 2020
Johns Hopkins and Bloomberg Philanthropies, with New York State, Launch Online Course to Train Army of Contact Tracers to Slow Spread of COVID-19
Johns Hopkins Bloomberg School of Public Health, with Bloomberg Philanthropies, today launched a free online course to help train a new cadre of contact tracers to reach and assist people exposed to the virus that causes COVID-19.
April 9, 2020
Experts Warn High Rates of Positive COVID-19 Tests Show U.S. Not Ready to Relax Restrictions; Also Note Signs in Africa of “Silent” Spread of Disease
The high percentage of positive results from COVID-19 tests indicates the United States has “not yet found the edges of the outbreak” and is not ready to transition from a stay-at-home strategy to a cautious return to normalcy.
March 27, 2020
Bloomberg Philanthropies, State of Maryland to Fund Johns Hopkins University-led COVID-19 Treatment Research
Bloomberg Philanthropies, Maryland Governor Larry Hogan and Johns Hopkins University announced today a joint effort to fund research into the potential therapeutic uses of COVID-19 convalescent plasma, led by infectious disease expert Arturo Casadevall.
March 13, 2020
Infectious Disease Experts Recommend Using Antibodies from COVID-19 Survivors as Stopgap Measure to Treat Patients and Protect Healthcare Workers
Countries fighting outbreaks of coronavirus should consider using the antibodies of people who have recovered from infection to treat cases and provide short-term immunity to critical health care workers, argue two infectious disease experts at JHSPH.
March 9, 2020
An analysis of publicly available data on infections from the new coronavirus, SARS-CoV-2, that causes the respiratory illness COVID-19 yielded an estimate of 5.1 days for the median disease incubation period, according to a new JHSPH-led study.
October 24, 2019
Inaugural Global Health Security Index Finds Significant Gaps in Preparedness for Epidemics and Pandemics
A new Global Health Security Index released today suggests that not a single country in the world is fully prepared to handle an epidemic or pandemic.